Anabasine as a precursor for the synthesis of potential agonists of neuronal acetylcholine receptors
暂无分享,去创建一个
[1] D. Donnelly-roberts,et al. ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders. , 2006, CNS drug reviews.
[2] T. Liljefors,et al. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. , 2005, Journal of medicinal chemistry.
[3] D. Donnelly-roberts,et al. Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors. , 1998, Journal of medicinal chemistry.
[4] J K Lynch,et al. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. , 1997, Journal of medicinal chemistry.
[5] P. Adams,et al. (S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors. , 1996, Journal of medicinal chemistry.